Invesco Biotechnology & Genome ETF
Invesco Biotechnology & Genome ETF (PBE) Options Open Interest
PBE options open interest is 84 contracts. The 2-week average daily volume is 0 contracts across the chain.
Read more
Monitoring PBE open interest helps you see where real money is positioned on Invesco Biotechnology & Genome ETF's options and which strikes are attracting the most commitment from traders. Invesco Biotechnology & Genome ETF's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor PBE options open interest in real time and find the strikes that matter.
Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising PBE options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Invesco Biotechnology & Genome ETF to settle.
The Invesco Biotechnology & Genome ETF (Fund) is based on the Dynamic Biotech & Genome Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Index is comprised of securities of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology and genetic engineering and research.
The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.
Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where PBE open interest is concentrated. Our scanner maps Invesco Biotechnology & Genome ETF's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Invesco Biotechnology & Genome ETF's options open interest as the signal it is, not as an afterthought.
| 83.00 | 10.30 | 15.10 | 12.70 | 7% | +1.0000 | 0 |
| 84.00 | 9.20 | 14.20 | 11.70 | 5% | +1.0000 | 0 |
| 85.00 | 8.30 | 13.30 | 10.80 | 5% | +1.0000 | 0 |
| 86.00 | 7.40 | 12.20 | 9.80 | 4% | +1.0000 | 0 |
| 87.00 | 6.50 | 11.30 | 8.90 | 4% | +1.0000 | 0 |
| 83.00 | — | 2.20 | 2.20 | 68% | -0.1967 | 0 |
| 84.00 | — | 2.20 | 2.20 | 65% | -0.2053 | 0 |
| 85.00 | — | 2.25 | 2.25 | 62% | -0.2166 | 0 |
| 86.00 | — | 2.30 | 2.30 | 59% | -0.2289 | 0 |
| 87.00 | — | 2.40 | 2.40 | 57% | -0.2440 | 0 |
As of September 17, 2026
Follow the money
Track PBE open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.
Start your 14-day free trial→